HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].

Abstract
Limb-girdle muscular dystrophy 2I (LGMD2I) is caused by mutations in the fukutin-related protein (FKRP) gene. Unlike its severe allelic forms, LGMD2I usually involves slower onset and milder course without defects in the central nervous system. The lack of viable animal models that closely recapitulate LGMD2I clinical phenotypes led us to use RNA interference technology to knock down FKRP expression via postnatal gene delivery so as to circumvent embryonic lethality. Specifically, an adeno-associated viral vector was used to deliver short hairpin (shRNA) genes to healthy ICR mice. Adeno-associated viral vectors expressing a single shRNA or two different shRNAs were injected one time into the hind limb muscles. We showed that FKRP expression at 10 months postinjection was reduced by about 50% with a single shRNA and by 75% with the dual shRNA cassette. Dual-cassette injection also reduced a-dystroglycan glycosylation and its affinity to laminin by up to 70% and induced α-dystrophic pathology, including fibrosis and central nucleation, in more than 50% of the myofibers at 10 months after injection. These results suggest that the reduction of approximately or more than 75% of the normal level of FKRP expression induces chronic dystrophic phenotypes in skeletal muscles. Furthermore, the restoration of about 25% of the normal FKRP level could be sufficient for LGMD2I therapy to correct the genetic deficiency effectively and prevent dystrophic pathology.
AuthorsChi-Hsien Wang, Yiumo Michael Chan, Ru-Hang Tang, Bin Xiao, Peijuan Lu, Elizabeth Keramaris-Vrantsis, Hui Zheng, Chunping Qiao, Jiangang Jiang, Juan Li, Hsin-I Ma, Qilong Lu, Xiao Xiao
JournalThe American journal of pathology (Am J Pathol) Vol. 178 Issue 1 Pg. 261-72 (Jan 2011) ISSN: 1525-2191 [Electronic] United States
PMID21224063 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Proteins
  • RNA, Small Interfering
  • Dystroglycans
  • Transferases
  • Fkrp protein, mouse
  • Pentosyltransferases
Topics
  • Adenoviridae
  • Animals
  • Cell Line, Tumor
  • Disease Models, Animal
  • Dystroglycans (metabolism)
  • Gene Knockdown Techniques (methods)
  • Genetic Vectors
  • Glycosylation
  • Mice
  • Mice, Inbred ICR
  • Muscle, Skeletal (metabolism, pathology)
  • Muscular Dystrophies, Limb-Girdle (genetics, metabolism, pathology)
  • Pentosyltransferases
  • Proteins (genetics)
  • RNA Interference
  • RNA, Small Interfering (genetics)
  • Transferases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: